Third Avenue Management SUPN Holdings History
Number of Shares
189,493.00
Current Holdings Value*
$6.21 Mil
% of Portfolio
1.24%
Total Estimate Gain
$171,466.97
% of Total Estimate Gain
2.93%
Third Avenue Management's Supernus Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Third Avenue Management held 189,493.00 shares of Supernus Pharmaceuticals Inc(SUPN), totaling $6.21 Mil. This investment constitutes 1.24% of their stock portfolio, and Third Avenue Management now holds 0.34% of the outstanding Supernus Pharmaceuticals Inc(SUPN) stock.
The initial trade took place in 2022Q2. And since then Third Avenue Management has made 6 purchases of SUPN, at an average price of $30.86, for a total of 189,493.00 shares. Based on historical transaction data and SUPN's current price of $31.76, Third Avenue Management's estimated gain on his SUPN holdings is $171,466.97, reflecting a 2.93% gain to date.
Third Avenue Management SUPN ($31.76) Holding Chart
Third Avenue Management SUPN ($31.76) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1